By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biocryst Pharmaceuticals 

2190 Parkway Lake Drive

Birmingham  Alabama  35244  U.S.A.
Phone: 205-444-4600 Fax:




Affinimark Technologies Inc. 

Company News
Why Biocryst (BCRX) Is A High-Risk High-Reward Stock 2/20/2017 6:21:26 AM
Biocryst (BCRX) To Announce Fourth Quarter And Year End 2016 Financial Results February 27 2/15/2017 8:19:42 AM
Biocryst (BCRX) Announces The Acceptance Of Peramivir MAA Filing By The EMA 1/30/2017 7:51:12 AM
Biocryst (BCRX) Receives Health Canada Approval For RAPIVABĀ® For The Treatment Of Influenza 1/9/2017 7:23:20 AM
Biocryst (BCRX) Reports Third Quarter 2016 Financial Results 11/7/2016 8:36:43 AM
Biocryst (BCRX) Announces Late Breaker Presentation Of Galidesivir (BCX4430) Nonclinical Results In Zika Virus Infection At IDWeek 2016 10/27/2016 8:29:01 AM
Biocryst (BCRX) To Announce Third Quarter 2016 Financial Results November 7 10/25/2016 8:56:55 AM
Biocryst (BCRX) Closes $23 Million Senior Credit Facility 9/26/2016 7:54:23 AM
Biocryst (BCRX) Announces Positive Study Results For BCX4430 Delayed Treatment Of Ebola Virus Infection In A Non-Human Primate Model 9/7/2016 10:01:25 AM
Biocryst (BCRX) To Present At The Baird 2016 Global Healthcare Conference September 8 9/1/2016 8:36:49 AM